January 29, 2018 / 1:20 PM / 8 months ago

BRIEF-Pernix Announces Patent Litigation Settlement Agreement With Actavis

Jan 29 (Reuters) - Pernix Therapeutics Holdings Inc:

* PERNIX ANNOUNCES PATENT LITIGATION SETTLEMENT AGREEMENT WITH ACTAVIS CONCERNING ZOHYDRO® ER

* PERNIX - UNDER TERMS, CO TO GRANT ACTAVIS LICENSE FOR SELLING A GENERIC VERSION OF ZOHYDRO(®) ER ON MARCH 1, 2029, OR EARLIER UNDER SOME CIRCUMSTANCES‍​‍​

* PERNIX - SETTLEMENT AGREEMENT ALSO RESOLVES A PENDING APPEAL RELATED TO A PATENT LITIGATION BETWEEN RECRO GAINESVILLE LLC AND ACTAVIS‍​

* PERNIX THERAPEUTICS HOLDINGS INC - OTHER DETAILS OF SETTLEMENT WITH ACTAVIS CONCERNING ZOHYDRO ER ARE CONFIDENTIAL

* PERNIX-PATENT LITIGATION BROUGHT BY CO AGAINST ALVOGEN MALTA OPERATIONS RELATED TO ALVOGEN’S PROPOSED GENERIC VERSION OF ZOHYDRO(®) ER REMAINS PENDING‍​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below